[LCID Study Number: 2018-083CIRB]
Lung-MAP: A master protocol to evaluate biomarker-driven therapies and immunotherapies in previously-treated non-small cell lung cancer (lung-MAP screening study)
Targeted Treatment for Advanced Non-Small Cell Lung Cancer
The purpose of this study is to find out if a targeted or immunotherapy treatment will have an effect on specific genes and proteins in your tumor.
Primary Contact Email: [email protected]
Primary Contact Phone: 781-744-3071